BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 30701345)

  • 1. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    Da Cunha T; Vaziri H
    J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
    Bye WA; Nguyen TM; Parker CE; Jairath V; East JE
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000279. PubMed ID: 28922695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A; Polyak S; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
    Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger ZR; Weizman AV
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):847-56. PubMed ID: 24621115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
    J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.